Dermata Therapeutics, Inc. DRMA Q1 2025 earnings
Reported May 14, 2025 · Before market open
EPS estimate-$0.45
Next report
Aug 18, 2026 (in a month)EPS estimate-$0.55
Versus estimates
Diluted EPS
Ask the moment Dermata Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Dermata Therapeutics, Inc. report Q1 2025 earnings?
- Dermata Therapeutics, Inc. (DRMA) reported Q1 2025 earnings on May 14, 2025 before market open.
- What were Dermata Therapeutics, Inc.'s Q1 2025 revenue and EPS?
- Dermata Therapeutics, Inc. reported diluted EPS of $-4.50 for Q1 2025.
- Did Dermata Therapeutics, Inc. beat estimates in Q1 2025?
- EPS missed the consensus estimate of $-0.45 by $4.05.
- How did Dermata Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS grew 36.2% from $-7.05.
- Where can I find Dermata Therapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001641172-25-010111) directly on SEC EDGAR. The filing index links above go to sec.gov.